Precipio Inc. (PRPO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

5.82

0.00%

After-hours Dec 13, 2024, 03:52 PM EST

Company Description

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.

It provides diagnostic blood cancer testing services.

The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests.

It sells ICE-COLD-PCR technology kits to bio-pharma customers.

Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.

The company is based in New Haven, Connecticut.

Precipio Inc.

Country	United States
IPO Date	Jun 30, 2017
Industry	Medical - Diagnostics & Research
Sector	Healthcare
Employees	51
CEO	Ilan Danieli

Contact Details

Address: 4 Science Park New Haven, Connecticut United States
Website	https://www.precipiodx.com

Stock Details

Ticker Symbol	PRPO
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001043961
CUSIP Number	74019L503
ISIN Number	US74019L6020
Employer ID	91-1789357
SIC Code	3826

Key Executives

Name	Position
Ilan Danieli	Founder, President, Chief Executive Officer & Director
Ahmed Zaki Sabet	Chief Operating Officer
Dr. Ayman A. Mohamed M.D.	Chief Technology Officer
Matthew Gage	Chief Financial Officer
Miri Chiko-Radomski	Chief Legal Counsel & People Officer

Latest SEC Filings

Date	Type	Title
Nov 12, 2024	4	Filing
Nov 07, 2024	8-K	Current Report
Nov 06, 2024	10-Q	Quarterly Report
Oct 17, 2024	4	Filing
Oct 17, 2024	4	Filing
Oct 17, 2024	4	Filing
Oct 17, 2024	4	Filing
Oct 17, 2024	4	Filing
Sep 06, 2024	4	Filing
Sep 06, 2024	4	Filing

View All SEC Filings